Solstice, which uses clinical and compliance documents and AI to accelerate advertising approvals for pharma clients, raised a $21M Series A (Brock E.W. Turner/Axios)
Brock E.W. Turner / Axios:
Solstice, which uses clinical and compliance documents and AI to accelerate advertising approvals for pharma clients, raised a $21M Series A — Pharma marketing company Solstice raised $21 million in Series A funding led by Transformation Capital, CEO Aris Saxena tells Axios Pro exclusively.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Wow
0
Sad
0
Angry
0
Comments (0)